Characterizing a Parkinson’s Disease Population Inadequately Controlled by Oral Therapy: Baseline Characteristics of the Phase 3 Clinical Program for Foslevodopa/Foscarbidopa (P2-11.006)
Abstract only
Gespeichert in:
| Veröffentlicht in: | Neurology 2023-04, Vol.100 (17_supplement_2) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 17_supplement_2 |
| container_start_page | |
| container_title | Neurology |
| container_volume | 100 |
| creator | Odin, Per Pahwa, Rajesh Farmer, Jill Kimber, Thomas Bergmans, Bruno Alvarez, Eric Freire Chaudhuri, K Ray Gupta, Resmi Yan, Connie H. Bergmann, Lars Kukreja, Pavnit Antonini, Angelo |
| description | Abstract only |
| doi_str_mv | 10.1212/WNL.0000000000202205 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1212_WNL_0000000000202205</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1212_WNL_0000000000202205</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1212_WNL_00000000002022053</originalsourceid><addsrcrecordid>eNqdUM1OwzAMjhBIjJ834OAjHLolKesGR8omkBD0MAluldemayBLitMhlROvwbvwNDwJqYRA4ogv9mf7-yx_jB0JPhRSyNH97c2Q_4TkUvLxFhuIsUyiJJYP22wQ2tMonk6mu2zP-0fOw3ByNmAfaY2ERatIv2q7AoQM6Ulb7-zn27uHS-0VegWZazYGW-0sXFss1fMGW2U6SJ1tyRmjSlh2cEdoYFErwqY7h4tANNoq-L3hW114cBW0ddCse-UY0rCki8DMyK0I11A5grnzRr240jU4CnWBtNQ9gONMRkKEf5OTA7ZTofHq8Dvvs9P5bJFeRQU570lVeUN6jdTlgue9U3lwKv_rVPxP2hfi4HTA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Characterizing a Parkinson’s Disease Population Inadequately Controlled by Oral Therapy: Baseline Characteristics of the Phase 3 Clinical Program for Foslevodopa/Foscarbidopa (P2-11.006)</title><source>Journals@Ovid Ovid Autoload</source><source>Alma/SFX Local Collection</source><creator>Odin, Per ; Pahwa, Rajesh ; Farmer, Jill ; Kimber, Thomas ; Bergmans, Bruno ; Alvarez, Eric Freire ; Chaudhuri, K Ray ; Gupta, Resmi ; Yan, Connie H. ; Bergmann, Lars ; Kukreja, Pavnit ; Antonini, Angelo</creator><creatorcontrib>Odin, Per ; Pahwa, Rajesh ; Farmer, Jill ; Kimber, Thomas ; Bergmans, Bruno ; Alvarez, Eric Freire ; Chaudhuri, K Ray ; Gupta, Resmi ; Yan, Connie H. ; Bergmann, Lars ; Kukreja, Pavnit ; Antonini, Angelo</creatorcontrib><description>Abstract only</description><identifier>ISSN: 0028-3878</identifier><identifier>EISSN: 1526-632X</identifier><identifier>DOI: 10.1212/WNL.0000000000202205</identifier><language>eng</language><ispartof>Neurology, 2023-04, Vol.100 (17_supplement_2)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>Odin, Per</creatorcontrib><creatorcontrib>Pahwa, Rajesh</creatorcontrib><creatorcontrib>Farmer, Jill</creatorcontrib><creatorcontrib>Kimber, Thomas</creatorcontrib><creatorcontrib>Bergmans, Bruno</creatorcontrib><creatorcontrib>Alvarez, Eric Freire</creatorcontrib><creatorcontrib>Chaudhuri, K Ray</creatorcontrib><creatorcontrib>Gupta, Resmi</creatorcontrib><creatorcontrib>Yan, Connie H.</creatorcontrib><creatorcontrib>Bergmann, Lars</creatorcontrib><creatorcontrib>Kukreja, Pavnit</creatorcontrib><creatorcontrib>Antonini, Angelo</creatorcontrib><title>Characterizing a Parkinson’s Disease Population Inadequately Controlled by Oral Therapy: Baseline Characteristics of the Phase 3 Clinical Program for Foslevodopa/Foscarbidopa (P2-11.006)</title><title>Neurology</title><description>Abstract only</description><issn>0028-3878</issn><issn>1526-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqdUM1OwzAMjhBIjJ834OAjHLolKesGR8omkBD0MAluldemayBLitMhlROvwbvwNDwJqYRA4ogv9mf7-yx_jB0JPhRSyNH97c2Q_4TkUvLxFhuIsUyiJJYP22wQ2tMonk6mu2zP-0fOw3ByNmAfaY2ERatIv2q7AoQM6Ulb7-zn27uHS-0VegWZazYGW-0sXFss1fMGW2U6SJ1tyRmjSlh2cEdoYFErwqY7h4tANNoq-L3hW114cBW0ddCse-UY0rCki8DMyK0I11A5grnzRr240jU4CnWBtNQ9gONMRkKEf5OTA7ZTofHq8Dvvs9P5bJFeRQU570lVeUN6jdTlgue9U3lwKv_rVPxP2hfi4HTA</recordid><startdate>20230425</startdate><enddate>20230425</enddate><creator>Odin, Per</creator><creator>Pahwa, Rajesh</creator><creator>Farmer, Jill</creator><creator>Kimber, Thomas</creator><creator>Bergmans, Bruno</creator><creator>Alvarez, Eric Freire</creator><creator>Chaudhuri, K Ray</creator><creator>Gupta, Resmi</creator><creator>Yan, Connie H.</creator><creator>Bergmann, Lars</creator><creator>Kukreja, Pavnit</creator><creator>Antonini, Angelo</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20230425</creationdate><title>Characterizing a Parkinson’s Disease Population Inadequately Controlled by Oral Therapy: Baseline Characteristics of the Phase 3 Clinical Program for Foslevodopa/Foscarbidopa (P2-11.006)</title><author>Odin, Per ; Pahwa, Rajesh ; Farmer, Jill ; Kimber, Thomas ; Bergmans, Bruno ; Alvarez, Eric Freire ; Chaudhuri, K Ray ; Gupta, Resmi ; Yan, Connie H. ; Bergmann, Lars ; Kukreja, Pavnit ; Antonini, Angelo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1212_WNL_00000000002022053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Odin, Per</creatorcontrib><creatorcontrib>Pahwa, Rajesh</creatorcontrib><creatorcontrib>Farmer, Jill</creatorcontrib><creatorcontrib>Kimber, Thomas</creatorcontrib><creatorcontrib>Bergmans, Bruno</creatorcontrib><creatorcontrib>Alvarez, Eric Freire</creatorcontrib><creatorcontrib>Chaudhuri, K Ray</creatorcontrib><creatorcontrib>Gupta, Resmi</creatorcontrib><creatorcontrib>Yan, Connie H.</creatorcontrib><creatorcontrib>Bergmann, Lars</creatorcontrib><creatorcontrib>Kukreja, Pavnit</creatorcontrib><creatorcontrib>Antonini, Angelo</creatorcontrib><collection>CrossRef</collection><jtitle>Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Odin, Per</au><au>Pahwa, Rajesh</au><au>Farmer, Jill</au><au>Kimber, Thomas</au><au>Bergmans, Bruno</au><au>Alvarez, Eric Freire</au><au>Chaudhuri, K Ray</au><au>Gupta, Resmi</au><au>Yan, Connie H.</au><au>Bergmann, Lars</au><au>Kukreja, Pavnit</au><au>Antonini, Angelo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterizing a Parkinson’s Disease Population Inadequately Controlled by Oral Therapy: Baseline Characteristics of the Phase 3 Clinical Program for Foslevodopa/Foscarbidopa (P2-11.006)</atitle><jtitle>Neurology</jtitle><date>2023-04-25</date><risdate>2023</risdate><volume>100</volume><issue>17_supplement_2</issue><issn>0028-3878</issn><eissn>1526-632X</eissn><abstract>Abstract only</abstract><doi>10.1212/WNL.0000000000202205</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-3878 |
| ispartof | Neurology, 2023-04, Vol.100 (17_supplement_2) |
| issn | 0028-3878 1526-632X |
| language | eng |
| recordid | cdi_crossref_primary_10_1212_WNL_0000000000202205 |
| source | Journals@Ovid Ovid Autoload; Alma/SFX Local Collection |
| title | Characterizing a Parkinson’s Disease Population Inadequately Controlled by Oral Therapy: Baseline Characteristics of the Phase 3 Clinical Program for Foslevodopa/Foscarbidopa (P2-11.006) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T14%3A46%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterizing%20a%20Parkinson%E2%80%99s%20Disease%20Population%20Inadequately%20Controlled%20by%20Oral%20Therapy:%20Baseline%20Characteristics%20of%20the%20Phase%203%20Clinical%20Program%20for%20Foslevodopa/Foscarbidopa%20(P2-11.006)&rft.jtitle=Neurology&rft.au=Odin,%20Per&rft.date=2023-04-25&rft.volume=100&rft.issue=17_supplement_2&rft.issn=0028-3878&rft.eissn=1526-632X&rft_id=info:doi/10.1212/WNL.0000000000202205&rft_dat=%3Ccrossref%3E10_1212_WNL_0000000000202205%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |